Animal Bioscience Inc. – Trademark Portfolio

Entity Type: 03

Animal Bioscience Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LY-D2 and LY-D6. The owner is based in Boston, MA.

361 Newbury St, 5th floor

Boston, MA 02115

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Animal Bioscience Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Animal Bioscience Inc. have?

Animal Bioscience Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does Animal Bioscience Inc. file in?

Animal Bioscience Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Animal Bioscience Inc.'s most well-known trademarks?

Animal Bioscience Inc.'s registered trademark portfolio includes well-known marks such as LY-D2 and LY-D6. These are among 2 currently registered trademarks in the portfolio.

What is Animal Bioscience Inc.'s trademark registration success rate?

Animal Bioscience Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.